Latest News

The winter 2018 edition of the National Glaucoma Research Report has information on a BrightFocus research grant that is leading to a new understanding of glaucoma, an article outlining the connection between diabetes and glaucoma, helpful facts about how clinical trials work, and much more.

A promising new strategy to protect the optic nerve in glaucoma, helpful information on clinical trials and why they are so important, and a study exploring the genes involved in closed-angle glaucoma, are among the articles available in the fall edition of the National Glaucoma Research Report.

The summer edition of National Glaucoma Research Report outlines new research into the causes of glaucoma, drug screenings, and therapeutic strategies by generating retinal ganglion cells in a dish; a Q/A with Jeffrey Goldberg, MD, PhD on the frontlines of discovery; a spotlight on Meredith Gregory-Ksander, PhD, and her research that may stop glaucoma development and vision loss; and much more.

Learn about experimental drugs implanted in the eye that may enhance visual function, the genetic risks of developing glaucoma, how glaucoma can occur even when eye pressures is a normal range, and much more in the winter 2017 edition of the National Glaucoma Research Report.

An experimental drug, consisting of cells manufactured and implanted in the eye to stimulate optic nerve growth and activity, could be an entirely new way of fighting glaucoma.

BrightFocus is funding a clinical trial to try to fight glaucoma with a new drug implanted in the eye that may protect the optic nerve.

The fall 2016 edition of the National Glaucoma Research Report explores a study examining the effects of pressure fluctuations on glaucoma that may lead to new treatment approaches, explains why a dilated eye exam is a must, provides vision tips for winter driving, and more.